This paper is in the following e-collection/theme issue:

Tools, Programs and Algorithms (246) Clinical Information and Decision Making (1340) Decision Support for Health Professionals (1147) Innovations in Cancer Diagnostic and Decision Support (52) Lung Cancer (30)

Published on in Vol 9, No 10 (2021): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/29017, first published .
An Automated Line-of-Therapy Algorithm for Adults With Metastatic Non–Small Cell Lung Cancer: Validation Study Using Blinded Manual Chart Review

An Automated Line-of-Therapy Algorithm for Adults With Metastatic Non–Small Cell Lung Cancer: Validation Study Using Blinded Manual Chart Review

An Automated Line-of-Therapy Algorithm for Adults With Metastatic Non–Small Cell Lung Cancer: Validation Study Using Blinded Manual Chart Review

Authors of this article:

Weilin Meng1 Author Orcid Image ;   Kelly M Mosesso2 Author Orcid Image ;   Kathleen A Lane2 Author Orcid Image ;   Anna R Roberts3 Author Orcid Image ;   Ashley Griffith3 Author Orcid Image ;   Wanmei Ou1 Author Orcid Image ;   Paul R Dexter3, 4, 5 Author Orcid Image
Article Authors Cited by (3) Tweetations (2) Metrics

Weilin Meng   1 , MEng ;   Kelly M Mosesso   2 , MA ;   Kathleen A Lane   2 , MS ;   Anna R Roberts   3 , MIS ;   Ashley Griffith   3 , MHA ;   Wanmei Ou   1 , PhD ;   Paul R Dexter   3, 4, 5 , MD

1 Center for Observational and Real-World Evidence, Merck & Co, Inc, Kenilworth, NJ, United States

2 Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, IN, United States

3 Regenstrief Institute, Inc, Indianapolis, IN, United States

4 Eskenazi Health, Indianapolis, IN, United States

5 Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States

Corresponding Author: